Intrinsic Value of S&P & Nasdaq Contact Us

Bruker Corporation BRKR NASDAQ

NASDAQ Global Select • Healthcare • Medical - Devices • US • USD

SharesGrow Score
58/100
2/7 Pass
SharesGrow Intrinsic Value
$14.00
-64.5%
Analyst Price Target
$52.13
+32%

Bruker Corporation (BRKR) — Analyst outlook / Analyst consensus target is. Based on 32 analyst ratings, the consensus is bullish — 16 Buy, 14 Hold, 2 Sell.

The consensus price target is $52.13 (low: $35.00, high: $60.00), representing an upside of 32% from the current price $39.48.

Analysts estimate Earnings Per Share (EPS) of $2.39 and revenue of $3.36B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $0.76 vs est $2.39 (missed -68.2%). 2025: actual $-0.15 vs est $1.88 (missed -108%). Analyst accuracy: 0%.

BRKR Stock — 12-Month Price Forecast

$52.13
▲ +32.04% Upside
Average Price Target
Based on 32 Wall Street analysts offering 12-month price targets for Bruker Corporation, the average price target is $52.13, with a high forecast of $60.00, and a low forecast of $35.00.
The average price target represents a +32.04% change from the last price of $39.48.
Highest Price Target
$60.00
Average Price Target
$52.13
Lowest Price Target
$35.00

BRKR Analyst Ratings

Buy
32
Ratings
16 Buy
14 Hold
2 Sell
Based on 32 analysts giving stock ratings to Bruker Corporation in the past 3 months
Rating breakdown
Buy
16 50%
Hold
14 44%
Sell
2 6%
50%
Buy
16 analysts
44%
Hold
14 analysts
6%
Sell
2 analysts

EPS Estimates — BRKR

0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $0.76 vs Est $2.39 ▼ 214.1% off
2025 Actual –$0.15 vs Est $1.88 ▼ 1,356.2% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.

Revenue Estimates — BRKR

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $3.366B vs Est $3.362B ▲ 0.1% off
2025 Actual $3.437B vs Est $3.422B ▲ 0.4% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message